Literature DB >> 21088158

Use of likelihood ratios improves interpretation of laboratory testing for pulmonary sarcoidosis.

Dieter De Smet1, Geert A Martens, Bram Vanden Berghe, Marc Meysman, Olivier Heylen, Frans K Gorus, Marc De Waele.   

Abstract

Laboratory tests for pulmonary sarcoidosis (percentage lymphocytes and CD4/CD8 ratio in bronchoalveolar lavage fluid and serum angiotensin-converting enzyme activity) lack sensitivity and specificity. In a retrospective study of 153 subjects under suspicion of pulmonary sarcoidosis (36 cases and 117 patients with other diseases [control patients]), we defined likelihood ratios (LRs) for rationally selected result intervals of these tests, which improve clinical interpretation as compared with dichotomous interpretation based on a single cutoff value. By using logistic regression analysis, we further integrated the 3 individual tests into a unified algorithm that could rule out diagnosis in 57 (48.7%) of the 177 control subjects and confirm diagnosis in 12 (33%) of the 36 pulmonary sarcoidosis cases. We conclude that use of LRs improves interpretation of laboratory tests for pulmonary sarcoidosis. In addition, we present a prediction algorithm based on the combination of laboratory tests that helps clinicians confirm or exclude diagnosis in almost half of the study population.

Entities:  

Mesh:

Year:  2010        PMID: 21088158     DOI: 10.1309/AJCPNC7STHG0FWMP

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Activated CD8(+) T cells and NKT cells in BAL fluid improve diagnostic accuracy in sarcoidosis.

Authors:  A Tøndell; A D Rø; A Åsberg; M Børset; T Moen; M Sue-Chu
Journal:  Lung       Date:  2013-11-10       Impact factor: 2.584

2.  Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis.

Authors:  Alexandra N Bickett; Elyse E Lower; Robert P Baughman
Journal:  Chest       Date:  2018-05-17       Impact factor: 9.410

3.  Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers.

Authors:  Gregorino Paone; Alvaro Leone; Sandro Batzella; Vittoria Conti; Francesco Belli; Laura De Marchis; Alice Mannocci; Giovanni Schmid; Claudio Terzano
Journal:  Inflamm Res       Date:  2012-12-23       Impact factor: 4.575

4.  Diagnostic Performance of Bronchoalveolar Lavage Fluid CD4/CD8 Ratio for Sarcoidosis: A Meta-analysis.

Authors:  Yongchun Shen; Caishuang Pang; Yanqiu Wu; Diandian Li; Chun Wan; Zenglin Liao; Ting Yang; Lei Chen; Fuqiang Wen
Journal:  EBioMedicine       Date:  2016-04-21       Impact factor: 8.143

5.  Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis.

Authors:  Milou C Schimmelpennink; Adriane D M Vorselaars; Marcel Veltkamp; Ruth G M Keijsers
Journal:  EJNMMI Res       Date:  2019-06-13       Impact factor: 3.138

Review 6.  Role of angiotensin-converting enzyme in myeloid cell immune responses.

Authors:  Duo-Yao Cao; Suguru Saito; Luciana C Veiras; Derick Okwan-Duodu; Ellen A Bernstein; Jorge F Giani; Kenneth E Bernstein; Zakir Khan
Journal:  Cell Mol Biol Lett       Date:  2020-05-25       Impact factor: 5.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.